Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Charles River Laboratories International Inc shares valued at $1,002,436 were purchased by FOSTER JAMES C on Feb 20 ’25. At $165.01 per share, FOSTER JAMES C acquired 6,075 shares. The insider’s holdings grew to 183,639 shares worth approximately $29.03 million following the completion of this transaction.
Also, Girshick Birgit purchased 1,514 shares, netting a total of over 249,250 in proceeds. Following the buying of shares at $164.63 each, the insider now holds 55,058 shares.
Before that, LaPlume Joseph W had sold 4,400 shares from its account. In a trade valued at $715,000, the EVP, Corp Strategy & Develop traded Charles River Laboratories International Inc shares for $162.50 each. Upon closing the transaction, the insider’s holdings decreased to 4,400 shares, worth approximately $3.16 million.
As published in a research note from Goldman on March 21, 2025, Charles River Laboratories International Inc [CRL] has been rated down from a Buy to a Neutral and the price target has been revised to $170 from $190. Analysts at Citigroup upgraded the stock from ‘”a Sell”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of March 03, 2025, Redburn Atlantic has increased its “Sell” rating to a “Neutral” for CRL. Earlier on January 22, 2025, William Blair downgraded its rating. Their new recommendation was “a Mkt perform” for CRL stock which previously was a “an Outperform”.
Analyzing CRL Stock Performance
During the last five days, there has been a drop of approximately -4.41%. Over the course of the year, Charles River Laboratories International Inc shares have dropped approximately -14.38%. Shares of the company reached a 52-week high of $193.56 on 01/07/25 and a 52-week low of $150.79 on 02/12/25. A 50-day SMA is recorded $165.27, while a 200-day SMA reached $191.60.
Support And Resistance Levels for Charles River Laboratories International Inc (CRL)
According to the 24-hour chart, there is a support level at 156.42, which, if violated, would cause prices to drop to 154.78. In the upper region, resistance lies at 159.39. The next price resistance is at 160.72. RSI (Relative Strength Index) is 39.54 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -8.88, which suggests the price will decrease in the coming days. Percent R is at 92.30%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
